Novo Nordisk is expanding discounted retail options for consumers who want to purchase the weight-loss medications Wegovy and ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Costco, which has eight CT stores, has signed a deal with Novo Nordisk to sell Wegovy and Ozempic injections at $499 per ...

A federal appeals court unanimously rejected a Novo Nordisk challenge to Medicare’s drug price negotiation program, a ruling ...

Moderately bullish activity in Novo Nordisk (NVO), with shares up 68c, or 1.16%, near $59.70. Options volume relatively light with 42k contracts ...

BENTONVILLE, Ark. — Sam's Club announced this week it will offer discounted prices for weight-loss drugs Ozempic and Wegovy, ...

Shares of Costco (NASDAQ:COST) have finally entered correction territory, dipping by close to 14% from its all-time highs.

Mounjaro recorded sales of Rs 85 crore in September. Analysts say user-friendly pen formulation helped build the momentum, ...

Health-care companies rose as traders rotated back into a sector that had fallen out of favor. Shares of insurers such as Humana and UnitedHealth Group added to recent gains following weak performance ...

India’s anti-obesity pharmaceutical market is valued at ₹859 crore, having recorded a five-fold increase over five years with ...

Novo Nordisk, the company that owns both Wegovy and Ozempic, will be selling the medicine at nearly half the out-of-pocket price of other pharmacies at just $499. The company’s U.S. president David ...

Mounjaro recorded Rs 80 crore in sales in September, trailing only GSK's antibiotic Augmentin, which registered Rs 85 crore ...